Sign in
4/A

Changes in Ownership

OptimizeRx Corp Filed Acc 0001628280-25-058715

Chief Finance & Strat Officer gave up 1,388 shares (to pay taxes)

  • Chief Finance & Strat Officer acquired 5,237 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Stelmakh Edward Chief Finance & Strat Officer 2025-12-19 Option exercise +5,237 128,218 D: show line 1 in the form
Stelmakh Edward Chief Finance & Strat Officer 2025-12-19 Shares withheld for taxes −1,388 $13.51 $18,752 126,830 D: show line 2 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Stelmakh Edward Chief Finance & Strat Officer 2025-12-19 Option exercise · Restricted Stock Units −5,237 5,237 D: show line 3 in the form
Loading xslF345X05/wk-form4a_1766517784.xml…